clinical trial · NCT07467733
Evaluation of the Safety and Preliminary Efficacy of Neuroinduced Mesenchymal Stem Cells and Exosome Therapy in Patients With Spinocerebellar Palsy
Biocells Medical·phase2·not yet recruiting·n = 90
Spinocerebellar Ataxia - All Sub-typesIntrathecal infusionIntranasal infusion
brief summary
This clinical study aims to evaluate the safety and preliminary therapeutic potential of mesenchymal stem cell-derived therapies in patients diagnosed with spinocerebellar palsy. The investigational treatment includes neuroinduced mesenchymal stem cells and their derived exosomes administered via intravenous and intranasal infusion.
started
Jun 1, 2026
primary completion
Jun 1, 2028
completion
Jun 1, 2029
last updated
Mar 12, 2026
official title
Phase I/II Randomized Controlled Study Evaluating the Safety and Preliminary Efficacy of Neuroinduced Mesenchymal Stem Cells and Exosome Therapy in Patients With Spinocerebellar Palsy
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol